Chinook Therapeutics, Inc.

Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Chinook Therapeutics, Inc. (NASDAQ: KDNY) resulting from allegations that Chinook may have issued materially misleading business information to the investing public.

If you purchased Chinook securities and would like to join the prospective action, please click “Join This Class Action.”

If you purchased Chinook securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Details of investigation:

On May 16, 2023, Muddy Waters Research issued a report on Chinook Therapeutics, Inc., alleging that atrasentan, the Company’s lead product candidate, “has been shown to be harmful to patients’ cardiovascular health”, and that “AbbVie and Chinook seem to have systemically manipulated research findings and presentation on atrasentan to obscure these trial results.”

On this news, Chinook Therapeutics stock dropped 4.5% on May 16, 2023.

Then, on June 7, 2023, Muddy Waters Research issued a follow-up report, further alleging that Chinook has manipulated its financial reporting, particularly as it relates to SanReno Therapeutics JV, which the report alleges to be an undisclosed related Chinese entity. The report specifically alleged that “Chinook uses SanReno to overstate revenues and assets.”

On this news, Chinook Therapeutics stock declined in intra-day trading.

Follow us on:
Company Name: Chinook Therapeutics, Inc.
Stock Symbol: KDNY
Class Period: N/A
Court: N/A

Why Rosen Law

The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.

Investors should carefully identify and select experienced counsel with a track record of success leading securities class actions. Often other firms issue press releases about class actions yet do not have comparable experience or resources.

Institutional Shareholders Services ranked the Rosen Law Firm # 1 for the number of securities class action recoveries in 2017.

The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.

Scroll to Top